Table 4. Complications and treatment of subjects with COVID-19 in different ages.
| All patients(n = 56) | NO. (%) | |||
|---|---|---|---|---|
| Age <60 years old(n = 34) | Age≥60 years old(n = 34) | P- value | ||
| Complications | ||||
| ARDS | 20(62.5%) | 5(38.5%) | 15(78.9%) | 0.030 |
| Sepsis shock | 7(21.9%) | 0(0.0%) | 7(36.8%) | 0.025 |
| DIC | 9(28.1%) | 2(15.4%) | 7(36.8%) | 0.178 |
| Arrhythmia | 14(43.8%) | 4(30.8%) | 10(52.6%) | 0.289 |
| Cardiac injury | 5(15.6%) | 1(7.7%) | 4(21.1%) | 0.625 |
| Gastrointestinal hemorrhage | 2(6.3%) | 0(0.0%) | 2(6.3%) | 0.502 |
| Treatment | ||||
| Antibacterial agents | 31(96.9%) | 13(100%) | 18(94.7%) | 1.000 |
| Glucocorticoids | 21(65.6%) | 7(53.8%) | 14(73.7%) | 0.283 |
| Immunoglobulin | 16(50.0%) | 3(23.1%) | 13(68.4%) | 0.029 |
| Renal replacement therapy | 13(40.6%) | 3(23.1%) | 10(52.6%) | 0.147 |
| ECMO | 12(37.5%) | 3(23.1%) | 9(47.4%) | 0.267 |
| Mechanical ventilation | ||||
| Invasive | 16(50.0%) | 3(23.1%) | 13(68.4%) | 0.029 |
Abbreviations: ARDS, Acute respiratory distress syndrome; DIC, Disseminated intravascular coagulation ECMO; Extracorporeal membrane oxygenation.